Under the new Central Bank of Sri Lanka Act, abbreviated as CBA, the Central Bank should use inflation targeting as its ...
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
Despite finishing strong across both its innovative and generic businesses in 2024, Teva’s cautious approach to the new year ...
The rumor that Biden spent nearly half of his presidency on vacation came from an exaggerated and incorrect Republican ...
IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...
To save taxpayer money and rebuild the economy, Congress should repeal Biden's poorly named Inflation Reduction Act ...
The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...
Panelists discuss how the inclusion of ibrutinib on the Inflation Reduction Act (IRA) negotiated drug price list could make it a more economically attractive first-line option, potentially influencing ...
On January 20, 2025, the White House issued an Executive Order titled Unleashing American Energy. Citing the detrimental effect of ...
In a recent episode of Oncology Unscripted, Dr. John Marshall, a renowned oncologist from Georgetown University, delves into the complex economics of cancer care in early 2025. As the new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback